*This is the Global version of our site. For specific country information, please choose from the dropdown.
Who we are
We are a biotechnology company committed to helping to address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Our leadership
Our team is composed of experts with an unparalleled knowledge of science, technology, and medicine. Their immense depth of experience is ideally suited to the quest to reduce the burden of infectious disease around the globe.
John C. Jacobs
President and Chief Executive Officer
Filip Dubovsky, MD MPH
President,
Research and Development
Research and Development
John J. Trizzino
President,
Chief Operating Officer
Chief Operating Officer
Mark Casey
Executive Vice President, Chief Legal Officer
Rick Crowley
Executive Vice President, Chief Operations Officer
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
Silvia Taylor
Executive Vice President, Chief Corporate Affairs and Advocacy Officer
Ian Watkins
Executive Vice President, Chief Human Resources Officer
Troy Morgan, JD
Senior Vice President, Chief Compliance Officer
Board of Directors
John C. Jacobs
President and Chief Executive Officer
James F. Young, PhD
Chairman of the Board of Directors
Gregg Alton
Director
Richard Douglas, PhD
Director
Rachel King
Director
Margaret G. McGlynn, R.Ph.
Director
David Mott
Director
Rick Rodgers, MBA
Director